![](/img/cover-not-exists.png)
An in-situ neoadjuvant vaccination with IL-12 and GM-CSF in biodegradable microspheres with systemic IL-2 provides protection against metastatic disease.
Hank C Hill, Michael Sabel, Nejat Egilmez, Richard B BankertVolume:
191
Year:
2000
Language:
english
Pages:
1
DOI:
10.1016/s1072-7515(00)00427-0
File:
PDF, 177 KB
english, 2000